Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SensoLyte® 520 Calpain Activity Assay Kit

Act, FRET Fluorometric
Catalog No. ABIN1882423

Quick Overview for SensoLyte® 520 Calpain Activity Assay Kit (ABIN1882423)

Target

Calpain

Detection Method

Fluorometric

Application

Activation (Act), Fluorescence Resonance Energy Transfer Microscopy (FRET)
  • Brand

    SensoLyte®

    Characteristics

    The SensoLyte® 520 Calpain Assay Kit is optimized for detecting calpain activity. This kit contains a novel internally quenched 5-FAM/QXL™ 520 FRET substrate. Calpain protease cleaves the FRET substrate into two separate fragments resulting in the release of 5-FAM fluorescence which can be monitored at excitation/emission= 490/520 nm. Increase in fluorescence is proportional to the calpain activity. The assay can detect both calpain 1 (µ) and 2 (m) activities and is ideal for kinetic study of these enzymes. The long wavelength fluorescence of 5-FAM is less interfered by the autofluorescence of components in biological samples and test compounds. The assays are performed in a convenient 96-well microplate format.
  • Comment

    FRET-based Assay Kit

    Restrictions

    For Research Use only
  • Handling Advice

    Aliquot as needed to avoid multiple freeze-thaw cycles. Protect Components A and B from light and moisture.

    Storage

    -80 °C

    Storage Comment

    Store all kit components, except Component D, at -20 °C. Store Component D at -80 °C. Component C can be stored at room temperature for convenience.
  • Jock, Leggett, Schuler, Callaghan, Levin: "Effect of partial bladder outlet obstruction and reversal on rabbit bladder physiology and biochemistry: duration of recovery period and severity of function." in: BJU international, Vol. 114, Issue 6, pp. 946-54, (2014) (PubMed).

    Kawashima, Umehara, Noma, Kawai, Shitanaka, Richards, Shimada: "Targeted disruption of Nrg1 in granulosa cells alters the temporal progression of oocyte maturation." in: Molecular endocrinology (Baltimore, Md.), Vol. 28, Issue 5, pp. 706-21, (2014) (PubMed).

    Callaghan, Johnson, Neumann, Leggett, Schuler, Levin: "The effect of partial outlet obstruction on calpain and phospholipase-2 activities: analyzed by severity and duration." in: Molecular and cellular biochemistry, Vol. 381, Issue 1-2, pp. 217-20, (2013) (PubMed).

    Kawashima, Liu, Mullany, Mihara, Richards, Shimada: "EGF-like factors induce expansion of the cumulus cell-oocyte complexes by activating calpain-mediated cell movement." in: Endocrinology, Vol. 153, Issue 8, pp. 3949-59, (2012) (PubMed).

    Novgorodov, Chudakova, Wheeler, Bielawski, Kindy, Obeid, Gudz: "Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis." in: The Journal of biological chemistry, Vol. 286, Issue 6, pp. 4644-58, (2011) (PubMed).

  • Target

    Calpain

    Background

    The calpains are a family of intracellular Ca2+ dependent cysteine proteases. The best-characterized calpains are isoforms 1 (µ) and 2 (m). They respond to Ca2+ signals by cleaving many specific proteins, thereby irreversibly modifying their function(s). Calpains are implicated in a variety of Ca2+ regulated cellular processes as well as various pathological phenomena such as ischemic injury, muscular dystrophy, diabetes, cataract, atherosclerosis, Alzheimer's disease, and cancer. Calpains represent potential therapeutic targets for drug discovery.
You are here:
Chat with us!